Fetal metabolic programming, epigenetics and the development of adult-onset diabetes: A narrative review of the literature

Authors

  • Edwin Dario Archila Hernandez Hospital Universitario de la Samaritana https://orcid.org/0000-0002-8633-8031
  • Gissela Martínez Defrancisco
  • Lina Paola Rojas Rojas

DOI:

https://doi.org/10.35454/rncm.v6n1.476

Keywords:

Epigenetics, Fetal metabolic programming, Diabetes, Nutrition

Abstract

Introduction: Epigenetics refers to the way in which genes are expressed in each individual depending on the intrauterine environment. Moreover, acquired genetic instructions can be evaluated. Disease progression and different research studies have shown the interaction between epigenetics and fetal metabolic programming in the development of chronic non-communicable diseases such as diabetes mellitus (DM) in adult life.

Objectives: To understand the mechanisms between epigenetics and fetal metabolic programming that lead to the onset of diabetes.

Methodology: A search was conducted in the PubMed, Scopus, Google Scholar and Scielo databases using a period between 2012 and 2022.

Results: Factors such as maternal body composition (undernutrition, overweight, obesity), nutrition, exercise and diseases during and before pregnancy are determinants of conditions such as low birth weight, intrauterine growth restriction and macrosomia, which behave as risk factors for developing DM, mainly driven by changes in DNA methylation and the intervention of some miRNAs.

Conclusions: Changes in eating habits, physical activity and breastfeeding are key factors during metabolic programming from the time of conception and are directly related to the development of DM. 

Downloads

Download data is not yet available.

References

Lehrke M, Marx N. Diabetes mellitus and heart failure. Am J Med. 2017;130(6):S40-S50. doi: 10.1016/j.amjmed.2017.04.010

Organización Panamericana de la Salud. Pacto mundial contra la diabetes. Implementación en la región de las Américas. 2021. Disponible en: https://www.paho.org/es/temas/diabetes/pacto-mundial-contra-diabetes-implementacion-region-americas#:~:text=El%20Pacto%20Mundial%20contra%20la,en%20un%20tercio%20para%202030

Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790. doi: 10.1038/S41598-020-71908-9

Zhu Z, Cao F, Li X. Epigenetic programming and fetal metabolic programming. Front Endocrinol (Lausanne). 2019;10:764. doi: 10.3389/FENDO.2019.00764

Casanello P, Krause BJ, Castro-Rodríguez JA, Uauy R. Programación fetal de enfermedades crónicas: conceptos actuales y epigenética. Rev Chil Pediatr. 2015;86(3):135-7. doi: 10.1016/j.rchipe.2015.06.008

De la Rosa M, Ledea L, Ferrea Y, Laffita A. Epigenética, desarrollo intrauterino y síndrome metabólico. Morfovirtual. 2018.

International Diabetes Federation. Home. [Acceso el 6 de noviembre de 2022]. Disponible en: https://idf.org/

Vargas-Uricoechea H, Casas-Figueroa LÁ. Epidemiología de la diabetes mellitus en Sudamérica: la experiencia de Colombia. Clin Investig Arterioscler. 2016;28(5):245-56. doi: 10.1016/j.arteri.2015.12.002

Cuenta de Alto Costo. Nuevo estudio de la CAC sobre la población con diabetes mellitus atendida en el marco del aseguramiento en Colombia. [Acceso el 6 de noviembre de 2022]. Disponible en: https://cuentadealtocosto.org/site/general/nuevo-estudio-de-la-cac-sobre-la-poblacion-con-diabetes-mellitus-atendida-en-el-marco-del-aseguramiento-en-colombia-fue-publicado-en-una-revista-internacional/

Kanter JE, Bornfeldt KE. Recent highlights of ATVB: Impact of diabetes. Arterioscler Thromb Vasc Biol. 2016;36(6):1049. doi: 10.1161/ATVBAHA.116.307302

Pandey A, Chawla S, Guchhait P. Type-2 diabetes: Current understanding and future perspectives. IUBMB Life. 2015;67(7):506-13. doi: 10.1002/IUB.1396

Rughani A, Friedman JE, Tryggestad JB. Type 2 diabetes in youth: The role of early life exposures. Curr Diabetes Reports. 2020;20(9):1-11. doi: 10.1007/S11892-020-01328-6

Fall CHD, Kumaran K. Metabolic programming in early life in humans. Philos Trans R Soc B Biol Sci. 2019;374(1770):20180123. doi: 10.1098/RSTB.2018.0123

Cahuana-Berrocal J, Donado-Gamez G, Barroso-Martínez L, González-Redondo N, Lizarazu-Diazgranados I, Iglesias-Acosta J. Epigenética y enfermedades crónicas no transmisibles. Arch Med. 2019;15:1-8. doi: 10.3823/1419

Franzago M, Fraticelli F, Stuppia L, Vitacolonna E. Nutrigenetics, epigenetics and gestational diabetes: Consequences in mother and child. Epigenetics. 2019;14(3):215. doi: 10.1080/15592294.2019.1582277

Nugent BM, Bale TL. The omniscient placenta: Metabolic and epigenetic regulation of fetal programming. Front Neuroendocrinol. 2015;39:28-37. doi: 10.1016/J.YFRNE.2015.09.001

Ruchat SM, Hivert MF, Bouchard L. Epigenetic programming of obesity and diabetes by in utero exposure to gestational diabetes mellitus. Nutr Rev. 2013;71:S88-94. doi:10.1111/NURE.12057

Langley-Evans SC. Nutrition in early life and the programming of adult disease: A review. J Hum Nutr Diet. 2015;28(1):1-14. doi: 10.1111/JHN.12212

Karachanak-Yankova S, Dimova R, Nikolova D, Nesheva D, Koprinarova M, Maslyankov S, et al. Epigenetic alterations in patients with type 2 diabetes mellitus. Balkan J Med Genet. 2016;18(2):15-24. doi: 10.1515/bjmg-2015-0081

Arroyo-Jousse V, Garcia-Diaz DF, Codner E, Pérez-Bravo F. Epigenetics in type 1 diabetes: TNFa gene promoter methylation status in Chilean patients with type 1 diabetes mellitus. Br J Nutr. 2016;116(11):1861-8. doi: 10.1017/S0007114516003846

González LM. Epigenética y diabetes [Tesis de grado]. Universidad de Valladolid. 2017.

Rodríguez Nájera G, Camacho Barquero FA, Umaña Bermúdez CA. Relación epigenética entre la desnutrición materna y la diabetes mellitus tipo 2. Rev Médica Sinerg. 2019;4(10):e278. doi: 10.31434/rms.v4i10.278

Collazo CR, Hernández Rodríguez Y, Campoverde DA. Lactancia materna, programación metabólica y su relación con enfermedades crónicas. Salud Uninorte Barranquilla. 2018;34(1):126-43. doi: 10.14482/sun.34.1.8923

Dunford AR, Sangster JM. Maternal and paternal periconceptional nutrition as an indicator of offspring metabolic syndrome risk in later life through epigenetic imprinting: A systematic review. Diabetes Metab Syndr Clin Res Rev. 2017;11:S655-S662. doi: 10.1016/J.DSX.2017.04.021

Cuinat C, Stinson SE, Ward WE, Comelli EM. Maternal intake of probiotics to program offspring health. Curr Nutr Rep. 2022;11:537-62. doi: 10.1007/s13668-022-00429-w

Hsu CN, Yu HR, Chan JYH, Wu KLH, Lee WC, Tain YL. The impact of gut microbiome on maternal fructose intake-induced developmental programming of adult disease. Nutrients. 2022;14(5):1031. doi: 10.3390/NU14051031

Vähämiko S, Laiho A, Lund R, Isolauri E, Salminen S, Laitinen K. The impact of probiotic supplementation during pregnancy on DNA methylation of obesity-related genes in mothers and their children. Eur J Nutr. 2019;58(1):367-77. doi: 10.1007/S00394-017-1601-1

Ziętek M, Celewicz Z, Szczuko M. Short-chain fatty acids, maternal microbiota and metabolism in pregnancy. Nutrients. 2021;13(4):1244. doi: 10.3390/NU13041244

Boswell N. Complementary feeding methods - A review of the benefits and risks. Int J Environ Res Public Health. 2021;18(13):7165. doi: 10.3390/IJERPH18137165

Fermín I, Milagro Y, Martínez J. Epigenética en obesidad y diabetes tipo 2: papel de la nutrición, limitaciones y futuras aplicaciones. Rev Chil Endocrinol Diabetes. 2013;6(3):108-14.

Barzallo P. Programación metabólica temprana. Rev Med Ateneo. 2018;20(1):83-92.

Sharp GC, Salas LA, Monnereau C, Allard C, Yousefi P, Everson TM, et al. Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: Findings from the pregnancy and childhood epigenetics (PACE) consortium. Hum Mol Genet. 2017;26(20):4067-85. doi: 10.1093/hmg/ddx290

Published

2023-03-23

How to Cite

Archila Hernandez, E. D., Martínez Defrancisco, G. ., & Rojas Rojas, L. P. (2023). Fetal metabolic programming, epigenetics and the development of adult-onset diabetes: A narrative review of the literature. Journal Clinical Nutrition and Metabolism, 6(1), 60–68. https://doi.org/10.35454/rncm.v6n1.476